Skip to content

Menopause symptoms: What's really happening, and what helps?

Up to 80 in 100 women get hot flashes, on top of changes in weight, focus, joints, sleep and skin, and often vaginal dryness. Most of it has a clear explanation, and for almost all of it there is something you can do.

Updated 21 min read55 sources

The short answer

The most common menopause symptoms are irregular periods, hot flashes and night sweats (up to 80 in 100 women), sleep problems, mood swings, brain fog, joint pain, more belly fat, vaginal dryness and bladder problems.[1, 3, 6] They usually start in perimenopause, years before the final period at about 51, and in women with frequent hot flashes those flashes last a median of 7.4 years.[1, 5] Hormone therapy is the most effective treatment for hot flashes, and when hormones are not an option, two newer non-hormonal prescription drugs and several older ones can help.[34, 35, 36, 37, 38] Most other symptoms have their own lever, such as resistance training plus protein to keep muscle[9, 32] or a short talking therapy for insomnia (CBT-I) for sleep.[24]

This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, exercise routine, or supplement regimen.

Am I in menopause? First signs and symptoms

You are in menopause once your period has been gone for 12 months in a row with no other cause, so the date is only certain in hindsight. Before that come the transition years, called perimenopause, and that is when most symptoms begin. SWAN, a large US study that has followed the same women through midlife, puts the average age of natural menopause at about 51.[1]

Doctors divide these transition years into stages with a system called STRAW+10. In that system the typical first sign is a cycle that changes, with periods coming closer together or further apart.[2] Our perimenopause guide goes through the stages step by step. This page stays with the practical question of which symptoms belong to the transition and what helps against each of them.

The table shows how common each symptom is and where on this page you find what helps:

Symptom How common More on this page
Hot flashes, night sweats up to 80 in 100 women across the transition,[1, 3]; about 7 in 10 respondents in a German survey[4] Hot flashes
Irregular periods the typical first sign of perimenopause[2] This section
Sleep problems, night waking no single figure; on the Menopause Rating Scale[6] Sleep
Low mood, irritability, anxiety, exhaustion no single figure; on the Menopause Rating Scale[6] FAQ
Racing heart, palpitations no single figure; on the Menopause Rating Scale[6] FAQ
Brain fog, forgetfulness common, usually temporary[11] Brain fog
Joint and muscle pain more than half of women[13] Joint pain
Belly fat, less muscle fat gain roughly doubles early in the transition[8] more of it at the belly.[22] Weight
Vaginal dryness, lower libido no single figure; on the Menopause Rating Scale[6] Vaginal dryness
Bladder problems about 4 in 10 respondents in a German survey[4] Vaginal dryness
Thinner skin collagen falls about 1 to 2 percent a year after menopause[16] Skin

Hot flashes and night sweats, which doctors call vasomotor symptoms, are the most common sign. Roughly 60 to 80 in 100 women get them during the transition, depending on the study and on whether mild flashes counted[1, 3] In a German postal survey of women aged 45 to 60, 81 percent of those who answered had experienced menopausal complaints at least once.[4] The table shows how many of them named hot flashes and bladder problems. Only about one in five women sent the questionnaire back, though, so women with complaints may be overrepresented in those figures.[4]

For many women those hot flashes last years, not months. In SWAN, women with frequent hot flashes had them for a median of 7.4 years in total and for another 4.5 years after the final period.[5] A median is the middle value, so half of these women had them for longer. Flashes that started early in the transition lasted longest, while those that began only after the final period lasted a median of about 3.4 years.[5] That is no reason to panic, but it is a good reason not to sit the complaints out if they are wearing you down.

Frequent hot flashes lasted years, not months

Median years of frequent hot flashes in US women: overall, after the final period, and when they began only after it

Overall7.4 yearsAfter menopause4.5 yearsLate start3.4 yearsOverall7.4 yearsAftermenopause4.5 yearsLate start3.4 years
Source: SWAN, Avis et al., JAMA Internal Medicine 2015

To sort your own complaints there is a well-validated self-assessment tool developed in Germany, the Menopause Rating Scale (MRS). It scores 11 complaints from 0 (none) to 4 (very severe), grouped into three domains.[6, 7]:

Domain Complaints (MRS items)
Physical (somatic) hot flashes and sweating, heart discomfort, sleep problems, joint and muscle complaints
Psychological depressed mood, irritability, anxiety, physical and mental exhaustion
Urogenital (vagina and bladder) sexual problems, bladder problems, vaginal dryness

The MRS is a self-check that prepares the conversation with your gynecologist, not a diagnosis, and our interactive menopause symptom checker walks you through it. When several of these complaints come together and your cycle turns irregular, perimenopause is the most likely explanation.

An irregular cycle still means you can get pregnant, because pregnancy remains possible until menopause is confirmed. The NHS advises using contraception until 2 years after your last period if you are under 50, or 1 year after it if you are 50 or older[46] That matters for this guide too, since several of the treatments in it must not be used in pregnancy.[37, 38, 41]

Some symptoms need a doctor rather than a self-check. That includes any vaginal bleeding once your period has been gone for 12 months and bleeding that gets heavier rather than lighter.[30] Most of the time the cause is harmless, but bleeding after menopause can be a sign of cancer, so a doctor needs to rule that out first.[30] Palpitations (a racing or pounding heart) also need a doctor if they keep coming back, last more than a few minutes, or occur with a known heart condition.[30, 43] Call emergency services (112) if palpitations do not stop or come with chest pain, shortness of breath or fainting.[43]

Hot flashes: What actually helps?

Hot flashes respond best to menopausal hormone therapy (MHT), which is the most effective treatment and first line in current guidelines.[34, 36] In placebo-controlled trials of hormone tablets it cut how often hot flashes came by about three quarters compared with placebo.[25] Placebo alone also helped noticeably in those trials, which is why any hot flash remedy needs a placebo comparison before you believe it works.[25] MHT is prescription-only,[52] and its benefit-risk balance is most favorable if you start before 60 or within 10 years of your last period.[34, 47]

That favorable balance does not apply to everyone. MHT may not be suitable if you have had breast, ovarian or womb cancer or blood clots, or if you have untreated high blood pressure or liver disease. If you still have a womb, estrogen is combined with a progestogen.[46] Whether it fits you is a conversation for your gynecologist, and the HRT guide covers the details.

If hormones are not an option, two newer non-hormonal drugs were made specifically for hot flashes: fezolinetant and elinzanetant.[37, 38] Both act on the brain's temperature control center, where they block a messenger (neurokinin) that helps set off the heat surge, and both are prescription-only.[37, 38] They are not the only route, though. Certain antidepressants (venlafaxine, paroxetine, escitalopram) and gabapentin also reduce hot flashes, although they were developed for other conditions.[35, 36] If you take tamoxifen for breast cancer, avoid paroxetine where possible, because it can make tamoxifen less effective, and agree the choice with your cancer team.[54] Menopause-specific CBT (cognitive behavioral therapy, a short talking therapy) has guideline support as well.[28, 35]

Fezolinetant (Veoza)

Fezolinetant has been approved in the EU since December 2023 and has been on the German market since February 2024.[37, 40] In the SKYLIGHT 1 trial it reduced moderate to severe hot flashes clearly more than placebo.[26] In rare cases it can damage the liver, so since early 2025 the EU product information requires a liver blood test before you start.[23, 37] After that the test is repeated every month for the first three months, and later as your doctor judges.[23, 37] Stop and call your doctor at once if you notice tiredness, itching, yellow skin or eyes, dark urine, pale stools, nausea or stomach pain.[37]

Veoza must not be taken during pregnancy, with contraceptive pills that contain ethinyl estradiol, or with certain other drugs such as fluvoxamine. If you could still get pregnant, the product information recommends non-hormonal contraception.[37] It is also not recommended with moderate to severe liver disease, during breast cancer treatment or alongside estrogen HRT that acts on the whole body.[37] Local vaginal estrogen is not affected by this.[37] In Germany's benefit assessment, which decides whether a new drug does better than existing options, the G-BA found no proven added benefit (as of October 2026).[40]

Elinzanetant (Lynkuet)

Elinzanetant has been approved in the EU since November 2025, and the approval also covers hot flashes caused by hormone-blocking breast cancer treatment.[38] In Germany it has been available on prescription since April 2026 (as of October 2026).[39] You take it once a day at bedtime, and in the OASIS 1 and 2 trials it reduced hot flashes and improved sleep compared with placebo.[27]

It can make you drowsy, so take care when driving, and it must not be used in pregnancy.[38] Do not combine it with strong blockers of the liver enzyme CYP3A4, such as the antifungal itraconazole or the antibiotic clarithromycin.[38] Avoid grapefruit and grapefruit juice while you take it as well.[38] Some other medicines, such as erythromycin or fluconazole, call for a lower dose of 60 mg a day, so tell your doctor everything you take.[38] Like Veoza, it is not recommended with moderate to severe liver disease or alongside estrogen HRT that acts on the whole body, while local vaginal estrogen can be used.[38] In its German benefit assessment the G-BA found no proven added benefit over hormone therapy or over watchful waiting.[39] The annual cost is about 1,130 euros (as of October 2026).[39]

What you can do yourself

A cool bedroom, layers you can peel off and less alcohol in the evening can make flashes easier to live with, but they have not been shown to reduce them. The North American menopause guideline does not recommend cooling techniques, avoiding triggers, exercise or supplements as a treatment for hot flashes.[35] So if hot flashes wreck your sleep or your days, that alone is reason enough to talk to your gynecologist about the medical options in this section.

Why am I gaining belly fat in menopause, and what helps?

Menopause on its own does not make the number on the scale jump; what shifts is where the fat goes. In SWAN, weight kept rising at the same pace as before, with no extra jump at the transition.[8] Body composition did change, though. At the start of the transition the rate of fat gain roughly doubled while lean mass (mostly muscle) began to fall.[8] That shift went on until about two years after the final period.[8]

More of that new fat lands at the belly and around the organs, where it is called visceral fat.[22] Visceral fat matters because it is an independent risk marker for type 2 diabetes and cardiovascular disease.[49] So a tightening waistband can reflect a meaningful change even when your weight barely moves.

What you can do is keep your muscle. Guidelines advise maintaining muscle mass and strength through physical activity during menopause.[28] In trials of postmenopausal women, resistance training improved everyday function and bone density and possibly reduced fat mass a little.[32] It did not clearly shrink waist size, though, and the certainty of this evidence is low to very low.[32] A second review confirms the strength side with clear gains in arms and legs, and it suggests three weekly sessions of about 60 minutes as a starting point.[53] That is a modest result, yet it works on the muscle side of the shift, the side the transition takes away.[8] The bone gains count as well, since bone density also falls after menopause and is worth raising with your doctor.[16, 30]

Protein is the other half of keeping muscle. For people over 65, the PROT-AGE expert group recommends 1.0 to 1.2 grams of protein per kilogram of body weight a day.[9] For those who exercise it advises 1.2 grams or more.[9] For women in midlife this is a reasonable target rather than a tested threshold. For a woman weighing 70 kilograms it means about 70 to 84 grams a day, roughly a palm-sized portion of quark, eggs, legumes, fish or poultry at each meal. If you have severe kidney disease, agree your protein intake with your doctor first.[9]

Hormone therapy does not help you lose weight. A Cochrane review of 28 randomized trials found no evidence that estrogen or combined hormone therapy changes body weight or prevents menopausal weight gain.[10] It also found too little data to judge fat distribution.[10] In a substudy of the large US Women's Health Initiative (WHI) trial, combined hormone therapy brought slightly less muscle loss and slightly less belly-area fat relative to leg fat.[48] The authors called these effects small.[48] Hormone therapy (MHT) is therefore no weight-loss drug and at most nudges body composition. Whether it makes sense for other symptoms is a question for the HRT guide, while training and protein stay the levers in your hands.

Brain fog: Why can't I concentrate, and is it dementia?

Concentrating worse, searching for words and feeling more forgetful are common in the menopause transition, and in the best data they look temporary. SWAN followed 2,362 women over four years with repeated memory and speed tests.[11] Normally people score a little better each time they repeat such tests, simply because they learn them. During perimenopause that usual improvement disappeared, and it came back after menopause.[11]

From that return, the researchers concluded that these difficulties may be time-limited.[11] SWAN measured test scores, not dementia, so it cannot rule dementia out for any individual woman. Even so, the typical brain fog of the transition, a dip that recovers, is not what dementia looks like in these data. See your doctor if memory problems keep coming back, get worse or affect your daily life.[45]

Bad nights and night sweats make any day harder, so it seems natural to blame them for the fog. SWAN tested that link directly: over six years, hot flashes and poor sleep did not explain the dip in test scores, while low mood and anxiety had small effects.[21] So treat sleep and hot flashes because they wear you down, not because they are proven to cause the fog.

Hormone therapy is no proven fix for the fog either, because it has not been shown to protect the brain, and in one trial it did harm. The WHI Memory Study (WHIMS) followed women aged 65 and over who started estrogen plus progestin.[12] Their risk of probable dementia roughly doubled, from 22 to 45 cases per 10,000 women per year.[12] Those women started hormones long after menopause, and the trial shows no benefit for memory, so brain fog alone gives no evidence-based reason to start MHT. The HRT guide covers timing and who it suits.

A note on the US label: the boxed warning is the FDA's strongest label warning. In November 2025 the agency announced it would remove the statements on cardiovascular disease, breast cancer and probable dementia from the one on hormone therapy.[47, 55] It also plans to add guidance on starting within 10 years of menopause or before 60.[47, 55] The boxed warning on womb cancer stays for estrogen-only products that act on the whole body.[55] Like the trial, this label change shows no benefit for memory.

For daily life, a reasonable approach is unglamorous. Move regularly, do tasks one after another rather than in parallel, and put important things into notes and lists while the transition lasts. Treating poor sleep still pays off for how you feel, and our sleep guide covers it in depth.

Joint pain in menopause: Is it estrogen, and what helps?

Estrogen probably plays a part in menopausal joint pain, but it is not the whole story. Joint pain affects more than half of women around menopause and seems to become more common with the transition. The leading explanation is the drop in estrogen, which normally has a hand in pain processing and in immune and cartilage cells.[13]

The best trial evidence for that estrogen link comes from the Women's Health Initiative.[14] A later analysis looked at 10,739 women without a uterus who took estrogen alone or a placebo.[14] After one year, joint pain was slightly less common on estrogen, at 76 versus 79 percent, which also shows how common sore joints were either way.[14] In a smaller group checked again at year three, the difference remained, though joint swelling was slightly more common on estrogen.[14] The authors call the effect modest, so read it as a pointer to the mechanism, not a treatment recommendation.

Before joint pain is put down to menopause, other causes need ruling out.[13] A review of the evidence calls menopausal joint pain real but understudied, and partly a diagnosis of exclusion: one made only after other causes are ruled out.[13] Some signs cannot wait for that check. If one joint suddenly becomes very painful, hot, swollen or red, or if joint pain comes with a fever, get an urgent appointment the same day.[44] Long-lasting morning stiffness, or swelling in several joints that does not settle, belongs in a routine visit. There your doctor can rule out osteoarthritis or an inflammatory rheumatic disease, both of which become more common at this age too.[13]

Once those causes are ruled out, there is no specific treatment for menopausal joint pain. The same review recommends exercise, weight loss and simple pain relief, especially if osteoarthritis is involved.[13] It also notes that hormone therapy can help some women who have bothersome hot flashes as well.[13] So movement is a sensible first step, while hormone therapy is mainly worth discussing when hot flashes are part of the picture, with your gynecologist and in our HRT guide.

Sleep problems and night sweats: What actually helps?

Cognitive behavioral therapy for insomnia, or CBT-I, is the best-supported first step against menopausal sleep problems.[24] The European insomnia guideline names this short, targeted therapy as the first-line treatment for adults.[24] That matters in menopause, because sleep problems are one of the 11 core complaints on the Menopause Rating Scale and are closely tied to night sweats.[6]

CBT-I teaches you to reset your sleep pressure (the drive to sleep that builds while you are awake) and your sleep-wake rhythm, rather than numbing the symptoms. A MsFLASH trial gave 106 women with hot flashes, before and after menopause, CBT-I by telephone and compared it with menopause education alone.[15] CBT-I brought clear and lasting gains in sleep quality and insomnia severity, large enough to make a real difference.[15] It also reduced how much hot flashes got in the way of daily life.[15] Since it worked while the hot flashes were still there, you do not have to wait for them to stop, nor do you necessarily need a sleeping pill.[15]

In Germany, CBT-I is within reach. Behavioral therapy can be covered by statutory health insurance as guideline psychotherapy (Richtlinienpsychotherapie, the talk therapies public insurers pay for). For insomnia there are also digital programs, and some can be prescribed as a health app (DiGA) that insurance pays for (as of October 2026). Waiting times for a therapy slot vary, so ask your doctor or insurer which options apply to you.

Sleep hygiene, covered in depth in our sleep guide, helps on top of CBT-I but does not replace it. It means fixed times, a cool dark bedroom, a screen break in the evening, and less caffeine and alcohol from late afternoon on. For night sweats, breathable bedding and light sleepwear make the nights more bearable, although they do not touch the cause.

If hot flashes are what keeps waking you, treat them too. The hot flash section of this guide describes the options, and one of the two newer drugs, elinzanetant, also improved sleep in its trials.[27] It can make you drowsy, though, so take care when driving.[38]

Skin aging and collagen loss: What happens, and what helps?

Skin does get thinner after menopause, and the best-known measurements come from the 1980s. In those studies, skin collagen and skin thickness fell by about 1 to 2 percent a year after menopause, in step with bone density.[16] You may also read that women lose 30 percent of their skin collagen in the first five years. That figure does not appear in the studies it is usually credited to, which makes it better travelled than it is sourced.

Small studies suggest that falling estrogen drives part of this loss. In one, skin collagen in untreated postmenopausal women tracked years since menopause rather than age, and women with hormone implants had more collagen.[17] A second study adds ordinary aging to the picture, because there collagen fell both with age and with years since menopause.[18] In a small study without a control group, women using estradiol gel for a year gained collagen in their abdominal skin.[19] These studies support the estrogen link, but they are small, and they give no reason to take hormones for your skin.

The best-proven skin measure is cheap: daily broad-spectrum sunscreen. In a randomized trial of adults under 55, people who used it every day showed no measurable increase in skin aging over four and a half years.[33] Their skin aged about a quarter less than that of people who used sunscreen only now and then.[33] Unlike the hormonal part of skin aging, sun exposure is something you control every day, and our skin-aging guide builds a full routine around it.

Among creams, the retinoid tretinoin (a vitamin A acid) is well studied. A review of 7 randomized trials found that it consistently improved wrinkles, uneven pigmentation, a dull sallow tone and age spots in sun-damaged skin.[20] It also stimulates new collagen.[20] First effects showed after about a month, and benefits lasted up to 24 months.[20] These were trials of sun-damaged skin in mostly female participants, not trials in menopausal women.[20] Do not use tretinoin or other retinoids if you are pregnant or planning a pregnancy.[41]

In Germany tretinoin is prescription-only.[52] Statutory insurance does not pay for drugs used mainly for quality of life, so if you use it for cosmetic reasons, you pay for it yourself.[51]

Vaginal dryness, painful sex and bladder problems: What helps?

Vaginal dryness, painful sex and bladder problems in menopause respond to local treatment: low-dose vaginal estrogen, non-hormonal moisturizers and lubricants, or both together.[28, 34] Doctors group these symptoms, along with urgency (a sudden strong need to pee) and repeated bladder infections, as the genitourinary syndrome of menopause.[34] The long name simply covers menopausal changes in the vagina and urinary tract. Bladder problems in particular are common: in a German survey, about 4 in 10 of the women who answered reported them.[4]

Choosing between vaginal estrogen and non-hormonal products for these symptoms depends on what bothers you and what you prefer.[28, 34] Low-dose vaginal estrogen comes as a cream, gel, tablet, pessary or ring.[28, 34] It works on its own or with a moisturizer or lubricant, and you can also use it alongside HRT that acts on the whole body.[28, 34] Only a minimal amount of it reaches the bloodstream, and serious side effects are very rare.[28] Symptoms often come back after you stop, and you can then start again.[28] If you cannot or would rather not use estrogen, moisturizers for everyday dryness and lubricants for sex are the alternative, and both come without a prescription.[28, 34]

In Germany vaginal estrogen (estradiol or estriol) is prescription-only, so the route goes through your gynecologist.[52] After breast cancer, start with non-hormonal products and consider vaginal estrogen only after talking with your oncology team.[28] Repeated bladder infections and urgency also need a medical check of their own.[28]

Where should treatment start?

Your Menopause Rating Scale answers are the most useful thing to bring to your gynecologist, because they show which complaints weigh on you most.[6] The scale scores each of its 11 complaints from 0 (none) to 4 (very severe).[6] A reasonable approach is to name your highest scores first and let them set the order of treatment. Its three domains help too, because physical complaints, mood, and vaginal or bladder problems each have their own options in this guide. The scale was also validated for measuring how symptoms change under hormone treatment, so filling it in again after starting therapy can show whether it is helping.[7]

If hot flashes top your list, the conversation will turn to hormone therapy, the most effective treatment for them.[34, 36] Its benefit-risk balance is most favorable before 60 or within 10 years of the last period.[34, 47] It may not be suitable after certain cancers or blood clots, or with liver disease.[46] The decision belongs with your gynecologist, and the HRT guide lays out the pros and cons so you can bring your questions along with your scale answers.

Frequently asked questions

When does menopause start, and what are the first signs?

Menopause itself only counts in hindsight, once your period has been gone for 12 months in a row, and the average age is about 51.[1] Symptoms usually begin years earlier, in perimenopause, and often the cycle changes first, with periods coming closer together or further apart.[2] Around the same time many women notice hot flashes, night sweats, poorer sleep and mood swings, and the 11 complaints of the Menopause Rating Scale help you sort them.[6]

Can menopause start at 40?

Perimenopause symptoms can start in your 40s, while menopause itself comes at about 51 on average.[1] If your periods become irregular or stop for four months or more before 40, see a gynecologist.[42] This can be premature ovarian insufficiency, meaning the ovaries stop working normally before 40, and it is diagnosed from that cycle change together with a blood test for FSH, a hormone that rises when the ovaries slow down.[42] Menopause between 40 and 44 is called early menopause; irregular periods at that age do not prove it on their own, because they are also typical of perimenopause.[2, 28, 42] Both matter because missing estrogen affects bones and heart, and with premature ovarian insufficiency hormone therapy is recommended at least until the usual age of menopause.[42]

How long do hot flashes in menopause last?

Often for years rather than months. In SWAN, women with frequent hot flashes and night sweats had them for a median of 7.4 years in total and for another 4.5 years after the final period.[5] They lasted longer the earlier they started, and shorter (median about 3.4 years) when they began only after the final period.[5] So the idea that it is over after a few months does not hold for many women.

What helps best against hot flashes?

Hormone therapy is the most effective treatment and first line in current guidelines,[34, 36] and in placebo-controlled trials of hormone tablets it cut hot flash frequency by about three quarters versus placebo.[25] It is prescription-only, and its benefit-risk balance is most favorable before 60 or within 10 years of the last period.[34, 47] Without hormones there are two newer prescription drugs, fezolinetant (Veoza) and elinzanetant (Lynkuet), which clearly beat placebo in large trials,[26, 27, 37, 38] plus certain antidepressants, gabapentin and menopause-specific CBT.[28, 35, 36] Veoza needs liver blood tests and must not be combined with pills containing ethinyl estradiol, and neither drug may be used in pregnancy.[37, 38]

How can I tell I am in menopause while on the pill?

It is harder than without it, because the combined pill causes regular withdrawal bleeds that hide the clearest sign, a changing cycle. Watch for other changes, like poorer sleep, mood swings or vaginal dryness. A hormone blood test (FSH) is not a reliable way to identify menopause while you take combined hormonal contraception.[28] Talk to your gynecologist about which contraception still suits you and when you can stop,[28, 46] and keep in mind that the hot flash drug Veoza must not be combined with pills containing ethinyl estradiol.[37]

Is a racing heart normal in menopause?

Heart discomfort such as palpitations or a racing heart is one of the 11 complaints on the Menopause Rating Scale,[6] so it is common, but not something to shrug off on your own. See a doctor if palpitations keep coming back, last more than a few minutes, or you have a heart condition or heart problems run in your family.[30, 43] Your doctor will decide which tests make sense, for example an ECG. Call 112 if palpitations do not stop or come with chest pain, shortness of breath or fainting.[43]

Can menopause affect your mood and mental health?

Yes, it can. Low mood, irritability, anxiety and exhaustion make up one of the three domains of the Menopause Rating Scale,[6] and the risk of depressive symptoms rises during the transition.[1] If low mood hangs on for weeks or you lose interest in things you used to enjoy, talk to your doctor, because it is treatable and not something to sit out. If you have thoughts of harming yourself, call the TelefonSeelsorge free on 0800 111 0 111 (Germany, around the clock) or 112 in an emergency.[50]

Do you inevitably gain weight in menopause?

No, menopause does not drive the number on the scale up on its own.[8] What shifts is fat distribution, with more fat at the belly and around the organs[22] and less muscle mass.[8] The best-supported way to keep muscle is resistance training plus enough protein,[9, 28, 32] and for people over 65 the PROT-AGE group recommends 1.0 to 1.2 g of protein per kg of body weight a day, more if you exercise.[9]

Does hormone therapy help with weight loss in menopause?

No. A Cochrane review of 28 trials found no evidence that estrogen or combined hormone therapy changes body weight or prevents weight gain.[10] One WHI substudy found slightly less muscle loss and a slightly lower ratio of trunk to leg fat on combined therapy, but the authors called the effects small.[48] MHT is not a weight-loss drug, and the full benefit-risk discussion is in the [HRT guide](/en/guide/hormonersatztherapie-hrt-trt).

Is brain fog in menopause a sign of dementia?

Usually it is not. In SWAN the learning dip during perimenopause recovered after menopause, which suggests it is temporary.[11] The study was not designed to detect dementia, so memory problems that keep coming back, get worse or affect daily life should be checked by a doctor.[45]

What helps most against sleep problems in menopause?

The guideline first-line treatment is cognitive behavioral therapy for insomnia (CBT-I).[24] In a MsFLASH trial of 106 women with hot flashes it brought clear, lasting improvements in sleep and insomnia compared with education alone, and it works even while hot flashes persist.[15] In Germany it may be accessible through statutory insurance as psychotherapy or as a prescribed app (DiGA), so ask your doctor or insurer which options apply (as of October 2026).

Does joint pain in menopause really come from estrogen?

It probably does in part. More than half of women around menopause have joint pain, and the estrogen drop is the leading explanation.[13] In a later analysis of the WHI estrogen-only trial, joint pain was slightly less common on estrogen than on placebo after one year (76 versus 79 percent), a modest effect.[14] Osteoarthritis and inflammatory rheumatic disease should be ruled out first, and a suddenly hot, swollen joint or joint pain with fever needs a doctor the same day.[13, 44]

What helps against skin aging in menopause?

The best-proven lever is daily broad-spectrum sunscreen, which slowed skin aging in a randomized trial.[33] Among creams, prescription tretinoin improved wrinkles, pigmentation and sallowness in 7 randomized trials of sun-damaged skin, with first effects after about a month,[20] but it must not be used in pregnancy or when planning one.[41] Small studies link skin collagen loss to falling estrogen, yet that is no reason to take hormones for your skin.[17, 18] More in the [skin-aging guide](/en/guide/hautalterung-stoppen).

What helps against vaginal dryness in menopause?

Low-dose vaginal estrogen as a cream, gel, tablet, pessary or ring and non-hormonal moisturizers or lubricants both help, alone or together, and the choice depends on your symptoms and preference.[28] Very little of the estrogen reaches the bloodstream, and serious side effects are very rare.[28, 34] In Germany vaginal estrogen is prescription-only,[52] and after breast cancer you start with non-hormonal products and consider estrogen only after talking with your oncology team.[28]

Can I still get pregnant during perimenopause?

Yes, until menopause is confirmed you can still get pregnant. The NHS advises contraception until 2 years after your last period if you are under 50, or 1 year after it if you are 50 or older.[46] Ask your gynecologist which method suits you, and keep in mind that Veoza, Lynkuet and tretinoin must not be used in pregnancy.[28, 37, 38, 41]

Are there non-hormonal medicines for hot flashes besides Veoza and Lynkuet?

Yes. Certain antidepressants (venlafaxine, desvenlafaxine, paroxetine, escitalopram) and gabapentin also reduce hot flashes, although they were developed for other conditions.[35, 36] The American College of Physicians' 2026 guideline even ranks venlafaxine or desvenlafaxine second line, ahead of gabapentin, the other antidepressants and the two newer drugs.[36] Menopause-specific CBT has guideline support too.[28, 35] If you take tamoxifen, paroxetine should be avoided where possible.[54]

Sources55

  1. El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, Karvonen-Gutierrez C, Waetjen LE, Matthews K. (2019). The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). Menopausedoi:10.1097/GME.0000000000001424
  2. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopausedoi:10.1097/gme.0b013e31824d8f40
  3. Thurston RC, Joffe H. (2011). Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation. Obstetrics and Gynecology Clinics of North Americadoi:10.1016/j.ogc.2011.05.006
  4. Buhling KJ, Daniels BV, Studnitz FSGV, Eulenburg C, Mueck AO. (2014). The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years. Complementary Therapies in Medicinedoi:10.1016/j.ctim.2013.12.004
  5. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicinedoi:10.1001/jamainternmed.2014.8063
  6. Heinemann K, Ruebig A, Potthoff P, Schneider HPG, Strelow F, Heinemann LAJ, Do MT. (2004). The Menopause Rating Scale (MRS) scale: a methodological review. Health and Quality of Life Outcomesdoi:10.1186/1477-7525-2-45
  7. Heinemann LAJ, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HPG. (2004). The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health and Quality of Life Outcomesdoi:10.1186/1477-7525-2-67
  8. Greendale GA, Sternfeld B, Huang MH, Han W, Karvonen-Gutierrez C, Ruppert K, Cauley JA, Finkelstein JS, Jiang SF, Karlamangla AS. (2019). Changes in body composition and weight during the menopause transition. JCI Insightdoi:10.1172/jci.insight.124865
  9. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Associationdoi:10.1016/j.jamda.2013.05.021
  10. Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. (2011). Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviewsdoi:10.1002/14651858.CD001018
  11. Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, Karlamangla AS. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurologydoi:10.1212/WNL.0b013e3181a71193
  12. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS). JAMAdoi:10.1001/jama.289.20.2651
  13. Magliano M. (2010). Menopausal arthralgia: fact or fiction. Maturitasdoi:10.1016/j.maturitas.2010.04.009
  14. Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J. (2013). Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopausedoi:10.1097/GME.0b013e31828392c4
  15. McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Tinker LF, LaCroix AZ. (2016). Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Internal Medicinedoi:10.1001/jamainternmed.2016.1795
  16. Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J. (1987). A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstetrics and GynecologyPubMed 3120067
  17. Brincat M, Moniz CJ, Studd JWW, Darby A, Magos A, Emburey G, Versi E. (1985). Long-term effects of the menopause and sex hormones on skin thickness. British Journal of Obstetrics and Gynaecologydoi:10.1111/j.1471-0528.1985.tb01091.x
  18. Affinito P, Palomba S, Sorrentino C, Di Carlo C, Bifulco G, Arienzo MP, Nappi C. (1999). Effects of postmenopausal hypoestrogenism on skin collagen. Maturitasdoi:10.1016/S0378-5122(99)00077-8
  19. Brincat M, Versi E, O'Dowd T, Moniz CF, Magos A, Kabalan S, Studd JWW. (1987). Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitasdoi:10.1016/0378-5122(87)90045-4
  20. Sitohang IBS, Makes WI, Sandora N, Suryanegara J. (2022). Topical tretinoin for treating photoaging: a systematic review of randomized controlled trials. International Journal of Women's Dermatologydoi:10.1097/JW9.0000000000000003
  21. Greendale GA, Wight RG, Huang MH, Avis N, Gold EB, Joffe H, Seeman T, Vuge M, Karlamangla AS. (2010). Menopause-associated symptoms and cognitive performance: results from the Study of Women's Health Across the Nation. American Journal of Epidemiologydoi:10.1093/aje/kwq067
  22. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. (2008). Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesitydoi:10.1038/ijo.2008.25
  23. European Medicines Agency; Astellas Pharma. (2025). Veoza (fezolinetant): risk of drug-induced liver injury and new recommendations on monitoring of liver function before and during treatment (DHPC)ema.europa.eu
  24. Riemann D, Espie CA, Altena E, Arnardottir ES, Baglioni C, Bassetti CLA, Bastien C, Berzina N, Bjorvatn B, Dikeos D, et al. (2023). The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Researchdoi:10.1111/jsr.14035
  25. MacLennan AH, Broadbent JL, Lester S, Moore V. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviewsdoi:10.1002/14651858.CD002978.pub2
  26. Lederman S, Ottery FD, Cano A, Santoro N, Shapiro M, Stute P, Thurston RC, English M, Franklin C, Lee M, Neal-Perry G. (2023). Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancetdoi:10.1016/S0140-6736(23)00085-5
  27. Pinkerton JV, Simon JA, Joffe H, Maki PM, Nappi RE, Panay N, Soares CN, Thurston RC, Caetano C, Haberland C, Haseli Mashhadi N, Krahn U, Mellinger U, Parke S, Seitz C, Zuurman L. (2024). Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMAdoi:10.1001/jama.2024.14618
  28. National Institute for Health and Care Excellence (NICE). (2026). Menopause: identification and management (NG23)nice.org.uk
  29. ESHRE Guideline Group on POI; Webber L, Davies M, Anderson R, et al. (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproductiondoi:10.1093/humrep/dew027
  30. NHS. (2026). Symptoms of menopause and perimenopausenhs.uk
  31. Faculty of Sexual & Reproductive Healthcare (FSRH). (2017). Contraception for Women Aged Over 40 Years (August 2017, amended May 2025)fsrh.org
  32. Sá KMM, da Silva GR, Martins UK, Colovati MES, Crizol GR, Riera R, Pacheco RL, Martimbianco ALC. (2023). Resistance training for postmenopausal women: systematic review and meta-analysis. Menopausedoi:10.1097/GME.0000000000002079
  33. Hughes MC, Williams GM, Baker P, Green AC. (2013). Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicinedoi:10.7326/0003-4819-158-11-201306040-00002
  34. The North American Menopause Society Advisory Panel. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopausedoi:10.1097/GME.0000000000002028
  35. The North American Menopause Society. (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopausedoi:10.1097/GME.0000000000002200
  36. Qaseem A, Mackey K, Yost J, Shekelle PG, Shamliyan TA, Cross JT Jr; Clinical Guidelines Committee of the American College of Physicians. (2026). Pharmacologic Treatments for Females With Menopausal Vasomotor Symptoms: A Clinical Guideline From the American College of Physicians. Annals of Internal Medicinedoi:10.7326/ANNALS-26-01205
  37. European Medicines Agency. (2023). Veoza (fezolinetant): EPAR product information (SmPC and package leaflet)ema.europa.eu
  38. European Medicines Agency. (2025). Lynkuet (elinzanetant): EPAR product information (SmPC and package leaflet)ema.europa.eu
  39. Gemeinsamer Bundesausschuss (G-BA). (2026). Nutzenbewertungsverfahren zum Wirkstoff Elinzanetant (Vasomotorische Symptome, mit der Menopause assoziiert), Vorgang 2026-04-01-D-1299; Beschluss vom 1. Oktober 2026g-ba.de
  40. Gemeinsamer Bundesausschuss (G-BA). (2024). Nutzenbewertungsverfahren zum Wirkstoff Fezolinetant (Vasomotorische Symptome (VMS), mit der Menopause assoziiert), Vorgang 2024-02-01-D-1035; Beschluss vom 1. August 2024g-ba.de
  41. European Medicines Agency. (2018). Retinoid-containing medicinal products: Article 31 referral (updated measures for pregnancy prevention)ema.europa.eu
  42. Panay N, Anderson RA, Bennie A, Cedars M, Davies M, et al.; ESHRE, ASRM, CRE-WHiRL and IMS Guideline Group on POI. (2024). Evidence-based guideline: premature ovarian insufficiency. Human Reproduction Opendoi:10.1093/hropen/hoae065
  43. NHS. (2026). Heart palpitationsnhs.uk
  44. NHS. (2026). Septic arthritisnhs.uk
  45. NHS. (2026). Memory loss (amnesia)nhs.uk
  46. NHS. (2026). About hormone replacement therapy (HRT)nhs.uk
  47. Sriprasert I, Hodis HN, Mack WJ, Rosser M, Evans ML, Xu X, Wright JD. (2026). Elimination of the Black Box Warning on Menopausal Hormone Therapy. Obstetrics & Gynecologydoi:10.1097/AOG.0000000000006226
  48. Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL. (2005). Postmenopausal hormone therapy and body composition: a substudy of the estrogen plus progestin trial of the Women's Health Initiative. American Journal of Clinical Nutritiondoi:10.1093/ajcn.82.3.651
  49. Neeland IJ, Ross R, Després JP, et al.; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity. (2019). Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes & Endocrinologydoi:10.1016/S2213-8587(19)30084-1
  50. TelefonSeelsorge Deutschland. (2026). TelefonSeelsorge: 0800 111 0 111 (kostenfrei, rund um die Uhr)telefonseelsorge.de
  51. Bundesrepublik Deutschland. (2026). § 34 SGB V: Ausgeschlossene Arznei-, Heil- und Hilfsmittelgesetze-im-internet.de
  52. Bundesrepublik Deutschland. (2026). Arzneimittelverschreibungsverordnung (AMVV), Anlage 1gesetze-im-internet.de
  53. González-Gálvez N, Moreno-Torres JM, Vaquero-Cristóbal R. (2024). Resistance training effects on healthy postmenopausal women: a systematic review with meta-analysis. Climactericdoi:10.1080/13697137.2024.2310521
  54. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). (2012). Tamoxifen: Mögliche reduzierte Wirksamkeit bei der Behandlung von Brustkrebs (Wechselwirkungen mit starken Inhibitoren des CYP2D6), Bescheid vom 14.11.2012bfarm.de
  55. U.S. Food and Drug Administration. (2025). FDA requests labeling changes related to safety information to clarify benefit/risk considerations for menopausal hormone therapyfda.gov

Talk about menopause, with women who get it

Become part of Longevity Switzerland. Trade notes on strength training, sleep, MHT conversations and finding the right gynecologist, with women in the same life window.

Join the community

Experts in this field

Speakers from the Longevity Switzerland community on this topic

Related guides

Created by Maurice Lichtenberg, Founder, Longevity Cities

The information provided here is for educational purposes only. Longevity Switzerland does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.